Susanne Beckebaum - Concepedia

Author

Susanne Beckebaum

Essen University Hospital

Also Known As

Angela Schlitt, Dadabhai Alim, S Beckebaum, S. BECKEBAUM, S. Beckebaum, S. Beckebaum, Susanne Beckebaum, T Seufferlein

288

Publications

8.3K

Citations

H-Index

113

Concepts

All Affiliations

Essen University Hospital University Hospital Münster Johannes Gutenberg University Mainz University of Duisburg-Essen Medizinische Hochschule Hannover

About

Susanne Beckebaum is an author at Essen University Hospital specializing in medicine, hepatology, and liver transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	41	3.9K
2	Health Sciences	3	3	75
3	Public Health	1	1	47
4	Social Sciences	1	1	47
5	Anatomy	1	1	12

Susanne Beckebaum

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma Edward K. Geissler, Andreas A. Schnitzbauer, C. Zülke, Transplantation	2015	409
Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial Paolo De Simone, Frank Nevens, Luciano De Carlis, American Journal of Transplantation	2012	325
A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation—PROTECT Lutz Fischer, J. Klempnauer, Susanne Beckebaum, American Journal of Transplantation	2012	188
Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study Faouzi Saliba, Paolo De Simone, Frank Nevens, American Journal of Transplantation	2013	180
Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion Qingli Shen, Vito R. Cicinnati, Xiaoyong Zhang, Molecular Cancer	2010	180
Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial Andrea Frilling, Gregor A. Stavrou, Hans‐Jörg Mischinger, Langenbeck s Archives of Surgery ThrombosisLiver ResectionHepatologyVascular SurgeryFibrinolysis	2005	177
Increased Levels of Interleukin-10 in Serum from Patients with Hepatocellular Carcinoma Correlate with Profound Numerical Deficiencies and Immature Phenotype of Circulating Dendritic Cell Subsets Susanne Beckebaum, Xia Zhang, Zhengya Yu, Clinical Cancer Research	2004	177
MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity Lei‐Bo Xu, Susanne Beckebaum, Speranța Iacob, Journal of Hepatology Ezh2 DownregulationCytostatic Drug SensitivityMedicineLiver PhysiologyPathology	2013	163
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma Andreas A. Schnitzbauer, Carl Zuelke, Christian Graeb, BMC Cancer	2010	159

Page 1